📋

Aetna — Ultrasound Abdomen

This page shows prior authorization criteria extracted from Aetna's published imaging guidelines. 115 matching coverage rules found for this procedure.

Coverage Rules from Aetna Policy

Abdominal Pain

Indication Code: AB-2.2

Abdominal Sepsis/Abscess

Indication Code: AB-3.1

Abdominal Ultrasound

Indication Code: AB-1.6

Abdominal Wall Mass

Indication Code: PEDAB-13.1

Abdominal Wall Mass

Indication Code: AB-13.1

Abnormal Liver Chemistries

Indication Code: AB-30.1

Acute Lymphoblastic Leukemia (ALL)

Indication Code: PEDONC-3.2

Acute Pancreatitis

Indication Code: PEDAB-34.1

Acute Pancreatitis

Indication Code: AB-33.1

Adrenal Lesions

Indication Code: PEDAB-17

Adrenal Lesions

Indication Code: PEDAB-17

Annual Surveillance

Indication Code: AB-4.4

Ascites

Indication Code: AB-26.2

Atypical Teratoid/Rhabdoid Tumors (ATRT)

Indication Code: PEDONC-4.5

Beckwith-Wiedemann Syndrome (BWS)

Indication Code: PEDONC-2.4

Bilateral Wilms Tumor (BWT)

Indication Code: PEDONC-7.3

Biliary Disease

Indication Code: PEDAB-16.2

Blunt Abdominal Trauma

Indication Code: AB-10.1

Cardiac Imaging in Transplants

Indication Code: CD-16

Chronic Liver Disease, Cirrhosis and Screening for HCC

Indication Code: AB-26.1

Chronic Pancreatitis

Indication Code: PEDAB-34.2

Chronic Pancreatitis

Indication Code: AB-33.2

Classical Hodgkin Lymphoma

Indication Code: ONC-28.2

Clear Cell Sarcoma of the Kidney (CCSK)

Indication Code: PEDONC-7.5

Costello Syndrome

Indication Code: PEDONC-2.14

Denys-Drash Syndrome (DDS)

Indication Code: PEDONC-2.5

Familial Adenomatous Polyposis (FAP) and Related Conditions

Indication Code: PEDONC-2.7

Fever of Unknown Origin (FUO)

Indication Code: ONC-30.1

Flank Pain, Renal Stone

Indication Code: PEDAB-4

Flank Pain, Renal Stone

Indication Code: PEDAB-4

Follow-Up of Treated Renal/Ureteral Stone

Indication Code: AB-4.3

General Considerations for Stem Cell Transplant

Indication Code: ONC-29.1

Generalized Abdominal Pain

Indication Code: PEDAB-2

Generalized Abdominal Pain

Indication Code: PEDAB-2

Hematuria

Indication Code: PEDAB-7

Hematuria

Indication Code: PEDAB-7

Hemophagocytic Lymphohistiocytosis (HLH)

Indication Code: PEDONC-18.3

Hepatic Arteries and Veins

Indication Code: AB-43.1

Hydrocephalus Shunts

Indication Code: HD-11.14

Hydrocephalus, Shunts, and Endoscopic Third Ventriculostomy (ETV)

Indication Code: PEDHD-7.3

Hydronephrosis

Indication Code: PEDAB-20

Hydronephrosis

Indication Code: PEDAB-20

Hydronephrosis of Unexplained or Indeterminate Cause

Indication Code: AB-39.4

Indeterminate Intra-Abdominal Mass

Indication Code: AB-13.2

Intra-Abdominal Mass

Indication Code: PEDAB-13.2

Intussusception

Indication Code: PEDAB-27

Intussusception

Indication Code: PEDAB-27

Isolated or Incidental Hepatomegaly

Indication Code: AB-29.4

Kidney Transplant, Post-Transplant

Indication Code: AB-42.6

Langerhans Cell Histiocytosis (LCH)

Indication Code: PEDONC-18.2

Li-Fraumeni Syndrome (LFS)

Indication Code: PEDONC-2.2

Liver Lesion Characterization

Indication Code: PEDAB-15

Liver Lesion Characterization

Indication Code: PEDAB-15

Liver Transplant, Post-Transplant Imaging

Indication Code: AB-42.3

Liver Transplant, Pre-Transplant

Indication Code: AB-42.1

Lower Extremity Artery Aneurysms

Indication Code: PVD-7.4

Lower Urinary Tract

Indication Code: PEDAB-5.2

LUMBAR Syndrome

Indication Code: PEDPVD-5.4

Malignant Rhabdoid Tumor of the Kidney (MRT) and Other Extracranial Sites

Indication Code: PEDONC-7.6

Melanoma – Surveillance/Follow-up

Indication Code: ONC-5.4

Monitoring After Fontan Procedure

Indication Code: AB-26.4

Multiple Endocrine Neoplasias (MEN)

Indication Code: PEDONC-2.8

Multiple Infantile Hemangiomas

Indication Code: PEDPVD-5.2

Observation of Known Renal/Ureteral Stone(s)

Indication Code: AB-4.2

Other Renal Cell Cancer Predisposition Syndromes

Indication Code: PEDONC-2.17

Pancreatic Cancer – Suspected/Diagnosis

Indication Code: ONC-13.2

Patent Urachus

Indication Code: PV-23.1

Pediatric Aggressive Mature B-Cell Non-Hodgkin Lymphomas (NHL)

Indication Code: PEDONC-5.3

Pediatric Liver Failure and Cirrhosis

Indication Code: PEDAB-16.1

Pelvic Pain/Dyspareunia, Female

Indication Code: PV-11.1

Polycystic Kidney Disease

Indication Code: PEDAB-21

Polycystic Kidney Disease

Indication Code: PEDAB-21

Polycystic Kidney Disease

Indication Code: AB-38.1

Portal Hypertension

Indication Code: AB-26.3

Post-Transplant Imaging

Indication Code: PEDONC-20.2

Postoperative Pain within 60 Days Following Abdominal Surgery

Indication Code: PEDAB-11

Postoperative Pain within 60 Days Following Abdominal Surgery

Indication Code: PEDAB-11

Pre-Transplant Imaging

Indication Code: PEDONC-20.1

Primary Sclerosing Cholangitis (PSC)

Indication Code: AB-23.4

Pyelonephritis

Indication Code: AB-40.1

Renal Failure

Indication Code: AB-36.1

Renovascular Hypertension and Other Secondary Causes of Hypertension

Indication Code: PEDAB-14

Renovascular Hypertension and Other Secondary Causes of Hypertension

Indication Code: PEDAB-14

Renovascular Hypertension/Renal Artery Stenosis

Indication Code: PVD-6.6

Retroperitoneal Fibrosis

Indication Code: AB-47.0

Retroperitoneal Ultrasound

Indication Code: AB-1.7

Rhabdoid Tumor Predisposition Syndrome

Indication Code: PEDONC-2.11

Right Lower Quadrant Pain

Indication Code: PEDAB-3

Right Lower Quadrant Pain

Indication Code: PEDAB-3

Right Upper Quadrant and Epigastric Pain

Indication Code: AB-2.3

Right Upper Quadrant Pain

Indication Code: PEDAB-8

Right Upper Quadrant Pain

Indication Code: PEDAB-8

Scoliosis

Indication Code: PEDSP-3.2

Screening for Vascular related genetic connective tissue Disorders

Indication Code: PVD-2.2

Small Vessel Vasculitis

Indication Code: PEDPVD-3.4

Small Vessel Vasculitis

Indication Code: PVD-6.11

Spleen

Indication Code: AB-34.1

Splenic Trauma

Indication Code: AB-34.2

Suspected Physical Child Abuse

Indication Code: PEDMS-7

Suspected Renal/Ureteral Stone(s)

Indication Code: AB-4.1

Transitional Cell Cancer – Initial Work-up/Staging

Indication Code: ONC-18.2

Tuberous Sclerosis Complex (TSC)

Indication Code: PEDONC-2.9

Ultrasound

Indication Code: AB-4.0

Unexplained Weight Loss

Indication Code: ONC-30.2

Unilateral Wilms Tumor (UWT)

Indication Code: PEDONC-7.2

Upper Urinary Tract

Indication Code: PEDAB-5.1

Ureteral and/or Bladder Trauma or Injury

Indication Code: PV-25.1

Urinary Incontinence – Initial Imaging

Indication Code: PV-22.1

Uterine Anomalies

Indication Code: PV-14.1

Visceral Artery Aneurysm

Indication Code: PVD-6.5

Visceral Artery Aneurysms

Indication Code: PEDPVD-4.3

Vomiting Infant, Malrotation, and Hypertrophic Pyloric Stenosis

Indication Code: PEDAB-33

Vomiting Infant, Malrotation, and Hypertrophic Pyloric Stenosis

Indication Code: PEDAB-33

Von Hippel-Lindau Syndrome (VHL)

Indication Code: PEDONC-2.10

Wilms Tumor-Aniridia-Growth Retardation (WAGR)

Indication Code: PEDONC-2.6

How to Submit a Prior Authorization Request

Submit via: Aetna Provider Portal (provider.aetna.com) or eviCore at 1-800-252-2021

📄 Required Documentation Checklist

  • Patient demographics and insurance information
  • Ordering provider NPI and contact information
  • Specific clinical indication with ICD-10 diagnosis code(s)
  • Relevant clinical history and physical exam findings
  • Results of prior conservative treatment (if applicable)
  • Prior imaging results relevant to the indication
  • Supporting lab or diagnostic results where applicable

⏱ Turnaround Times

Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.

📣 Appeal Window

Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.

⚠ Common Denial Reasons

  • Insufficient clinical documentation to establish medical necessity
  • Clinical criteria not met per payer guidelines
  • Lack of documented prior conservative treatment
  • Missing required prior imaging as step therapy
  • Incorrect or unsupported ICD-10 diagnosis code pairing
  • Request submitted outside of authorization timeframe

Clinical Approval Criteria

✓ Generally Approved When:

  • Low PA burden — most plans cover abdominal ultrasound for appropriate indications without prior auth
  • Limited ultrasound (76705) vs. complete (76700): document whether a limited targeted exam is sufficient
  • Surveillance ultrasound (cirrhosis/HCC): document cirrhosis diagnosis and surveillance interval
← Back to Ultrasound Abdomen overview Search Coverage Database →
Disclaimer: Coverage criteria shown on this page are sourced from publicly available payer guidelines and are provided for informational and educational purposes only. Prior authorization requirements change frequently. Always verify current criteria directly with the payer or their delegated utilization management company before submitting an authorization request. This page does not constitute medical or legal advice.